Neisseria mucosa Urinary Tract Infection in a Neonate With Posterior Urethral Valves: A Case Report
Abstract
Neisseria mucosa is a Gram-negative diplococcus that usually colonizes the upper respiratory tract and is generally regarded as a commensal organism. It has, nevertheless, been implicated as an opportunistic pathogen in bacteremia, endocarditis, septic arthritis, meningitis, and peritoneal dialysis-associated peritonitis; urinary tract infection (UTI) remains exceptionally rare. We report a UTI caused by N. mucosa in a 24-day-old male neonate with posterior urethral valves (PUVs), who presented with frank pyuria for 10 days. Direct Gram staining of urine revealed Gram-negative diplococci with a coffee-bean morphology, and the organism was recovered in pure culture. Species identification was achieved by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Antimicrobial susceptibility testing by ETEST® showed susceptibility to ceftriaxone and resistance to benzylpenicillin and ciprofloxacin. Treatment with ceftriaxone was associated with a favorable clinical and biological outcome. This case illustrates the opportunistic potential of N. mucosa in neonates with structural urinary tract abnormalities and emphasizes the value of accurate microbiological identification when UTIs occur in an unusual clinical setting.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.